Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alcolea

Showing results (31-40 of 241) with videos related to

Pageof 25
Sort By:
American Journal of Alzheimer'S Disease and Other Dementias|May 23, 2013
Comparison of 2 diagnostic criteria for the behavioral variant of frontotemporal dementiaSónia Costa, Marc Suárez-Calvet, Sofia Antón, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 28, 2023
Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation studyYanaika S Hok-A-Hin, Katharina Bolsewig, Daimy N Ruiters, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 11, 2015
Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseasesLaura Cervera-Carles, Javier Pagonabarraga, Berta Pascual-Sedano, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLDDaniel Alcolea, David J Irwin, Ignacio Illán-Gala, et al.
Brain Communications|May 20, 2025
Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuumCene Jerele, Antonios Tzortzakakis, Milan Nemy, et al.
Brain and Behavior|February 9, 2022
Neuropsychological deficits in patients with cognitive complaints after COVID-19Carmen García-Sánchez, Marco Calabria, Nicholas Grunden, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 4, 2018
Challenges associated with biomarker-based classification systems for Alzheimer's diseaseIgnacio Illán-Gala, Jordi Pegueroles, Victor Montal, et al.
Molecular Neurobiology|September 16, 2016
Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and LimitationsMarta Cosín-Tomás, Anna Antonell, Albert Lladó, et al.
Brain Communications|November 21, 2025
Sleep-related changes in astrocytic biomarkers are modulated by <i>APOE</i> ε4 genotype in cognitively unimpaired adultsNuole Zhu, Miren Altuna, Javier Arranz, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 5, 2019
Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's DiseaseJose L Cantero, Mercedes Atienza, Carmen Lage, et al.
Pageof 25

Showing results (31-40 of 241) with videos related to

Sort By:
Pageof 25
American Journal of Alzheimer'S Disease and Other Dementias|May 23, 2013
Comparison of 2 diagnostic criteria for the behavioral variant of frontotemporal dementiaSónia Costa, Marc Suárez-Calvet, Sofia Antón, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 28, 2023
Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation studyYanaika S Hok-A-Hin, Katharina Bolsewig, Daimy N Ruiters, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 11, 2015
Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseasesLaura Cervera-Carles, Javier Pagonabarraga, Berta Pascual-Sedano, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLDDaniel Alcolea, David J Irwin, Ignacio Illán-Gala, et al.
Brain Communications|May 20, 2025
Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuumCene Jerele, Antonios Tzortzakakis, Milan Nemy, et al.
Brain and Behavior|February 9, 2022
Neuropsychological deficits in patients with cognitive complaints after COVID-19Carmen García-Sánchez, Marco Calabria, Nicholas Grunden, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 4, 2018
Challenges associated with biomarker-based classification systems for Alzheimer's diseaseIgnacio Illán-Gala, Jordi Pegueroles, Victor Montal, et al.
Molecular Neurobiology|September 16, 2016
Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and LimitationsMarta Cosín-Tomás, Anna Antonell, Albert Lladó, et al.
Brain Communications|November 21, 2025
Sleep-related changes in astrocytic biomarkers are modulated by <i>APOE</i> ε4 genotype in cognitively unimpaired adultsNuole Zhu, Miren Altuna, Javier Arranz, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 5, 2019
Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's DiseaseJose L Cantero, Mercedes Atienza, Carmen Lage, et al.
Pageof 25